GR3025376T3 - Salts of nefazodone having improved dissolution rates - Google Patents

Salts of nefazodone having improved dissolution rates

Info

Publication number
GR3025376T3
GR3025376T3 GR970403019T GR970403019T GR3025376T3 GR 3025376 T3 GR3025376 T3 GR 3025376T3 GR 970403019 T GR970403019 T GR 970403019T GR 970403019 T GR970403019 T GR 970403019T GR 3025376 T3 GR3025376 T3 GR 3025376T3
Authority
GR
Greece
Prior art keywords
salts
nefazodone
dissolution rates
improved dissolution
dissolution
Prior art date
Application number
GR970403019T
Other languages
English (en)
Inventor
Hemant N Joshi
Terry D Wilson
Jatin M Patel
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of GR3025376T3 publication Critical patent/GR3025376T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GR970403019T 1994-11-02 1997-11-13 Salts of nefazodone having improved dissolution rates GR3025376T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33339094A 1994-11-02 1994-11-02

Publications (1)

Publication Number Publication Date
GR3025376T3 true GR3025376T3 (en) 1998-02-27

Family

ID=23302579

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970403019T GR3025376T3 (en) 1994-11-02 1997-11-13 Salts of nefazodone having improved dissolution rates

Country Status (10)

Country Link
US (1) US6034085A (el)
EP (1) EP0710653B1 (el)
JP (1) JPH08208480A (el)
AT (1) ATE157659T1 (el)
AU (1) AU689645B2 (el)
CA (1) CA2160423A1 (el)
DE (1) DE69500652T2 (el)
DK (1) DK0710653T3 (el)
ES (1) ES2107280T3 (el)
GR (1) GR3025376T3 (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
KR100398791B1 (ko) * 1998-04-24 2003-09-19 스카리스타 리미티드 우울증 치료 및 그 용도의 약리학적 제제
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
ATE323493T1 (de) * 1998-11-02 2006-05-15 Alza Corp Gesteuerte freisetzung von antidepressiva
US7087372B2 (en) * 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030194756A1 (en) * 2002-04-12 2003-10-16 O'connor Thomas Patrick Peptides for detection of antibody to Ehrlichia equi
US7407770B2 (en) * 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030129680A1 (en) * 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
US7183060B2 (en) * 2005-02-22 2007-02-27 Idexx Laboratories, Inc. Peptides for detection of antibody to Ehrlichia ewingii
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
JP5244318B2 (ja) * 2003-12-31 2013-07-24 シーマ・ラブス、インコーポレイテッド 発泡性経口アヘン薬投薬形態およびアヘン薬の投与方法
WO2005065317A2 (en) * 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
EA010826B1 (ru) * 2003-12-31 2008-12-30 Сайма Лэбс Инк. Лекарственная форма фентанила для перорального применения, способ ее получения и способы лечения
US20060069060A1 (en) * 2004-09-27 2006-03-30 Sanjeev Redkar Salts of decitabine
US20060063735A1 (en) * 2004-09-17 2006-03-23 Supergen, Inc. Salts of 5-azacytidine
US7507789B2 (en) * 2007-04-09 2009-03-24 Idexx Laboratories, Inc. Detection of Anaplasma platys
BRPI0817202B1 (pt) 2007-09-21 2018-11-21 Idexx Lab Inc polipeptídeo purificado e método de detecção de anticorpos que se ligam especificamente a um polipeptídio do ehrlichia chaffeensis em uma amostra em teste
MX2010002947A (es) * 2007-09-21 2010-08-04 Idexx Lab Inc Metodos y composiciones para deteccion de ehrlichia chaffeensis (p120).
US8158370B2 (en) * 2007-11-27 2012-04-17 Idexx Laboratories, Inc. Anaplasma phagocytophilum (Aph) antigens and antibodies specific for Anaplasma
CA2739796C (en) 2008-10-08 2018-11-06 Idexx Laboratories, Inc. Compositions and methods for detection of antibodies specific for anaplasma phagocytophilum (aph) and anaplasma platys (apl)
EP3045043B1 (en) 2009-02-26 2020-04-29 Relmada Therapeutics, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
US9133525B2 (en) 2012-01-26 2015-09-15 Luc Montagnier Detection of DNA sequences as risk factors for HIV infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
IT1196429B (it) * 1986-07-01 1988-11-16 Mediolanum Farmaceutici Srl Processo per la preparazione di pirido benzotiazine ad attivita' antibatterica e loro sali con acidi solfonici
US5188836A (en) * 1990-07-27 1993-02-23 Warner-Lambert Company Sustained release formulations
TW279864B (el) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv

Also Published As

Publication number Publication date
US6034085A (en) 2000-03-07
ES2107280T3 (es) 1997-11-16
EP0710653B1 (en) 1997-09-03
DK0710653T3 (da) 1997-12-08
AU3458395A (en) 1996-05-09
EP0710653A1 (en) 1996-05-08
CA2160423A1 (en) 1996-05-03
ATE157659T1 (de) 1997-09-15
JPH08208480A (ja) 1996-08-13
AU689645B2 (en) 1998-04-02
DE69500652T2 (de) 1998-02-19
DE69500652D1 (de) 1997-10-09

Similar Documents

Publication Publication Date Title
GR3025376T3 (en) Salts of nefazodone having improved dissolution rates
TR199600498A2 (tr) S(+)-ibuprofen'in oral formülasyonlari.
AR064896A2 (es) Composicion farmaceutica no higroscopica
LU91290I2 (fr) Céfovécine, optionnellement sous la forme d'un sel, dont le sel de sodium (CONVENIAr)
HU0200688D0 (en) Pharmaceutical formulations with improved release containing solid salts of racemic thioctic acid
LU91306I2 (fr) Mitratapide, optionnellement sous forme d'un sel d'addition acide pharmaceutiquement acceptable (YARVITAN)
AU6945491A (en) Pimobendan compositions
ITRM950480A0 (it) Metodo per aumentare la rapidita' di allevamento di neonati mediante impiego di mangime per scrofe da riproduzione.
IL98574A0 (en) Piperidyl-substituted indoles
ZA973495B (en) Matrix tablet allowing the prolonged release of the sodium salt of tianeptine after administration by the oral route.
EP1069107A4 (en) FULLERENE DERIVATIVES
FR2678836B1 (fr) Formulations pour voie orale d'ubidecarenone sous la forme de solutions aqueuses.
GB2135997B (en) N-(m-trifluoromethylphenyl)-n'-propargylpiperazine
AU6849594A (en) Orientation aid for use when swimming on the back
TR199902117T2 (xx) (E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-�ndol-2-karboksilik asidin kristalimsi hidratlanm�� sodyum tuzu.
IL104049A0 (en) 7'-amino-naphthazarin antibiotic derivatives
FR2798279B1 (fr) Dispositif d'insemination artificielle, notamment pour la reproduction des porcs
FR2794328B1 (fr) Decodeur de sequence d'image pour avance rapide
ZA902167B (en) Thienylpiperazines,process for the preparation thereof,the use thereof,and pharmaceuticals containing these and the preparation thereof
ITPD950047A0 (it) Telecamera endoscopica, in particolare per la ripresa di immagini della cavita' orale
DK336088A (da) Antitumormiddel opnaaet ved mikrobiel stereoselektiv reduktion af 4'-deoxy-4'-ioddoxorubicin
FR2782444B1 (fr) Dispositif d'amelioration de la tetee des porcelets nouveaux-nes
PT82535A (en) Pharmacologically active propionylanilides